Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tymms

Showing results (121-130 of 152) with videos related to

Pageof 16
Sort By:
Annals of the Rheumatic Diseases|April 1, 1992
Occurrence of (E)-4-hydroxy-2-nonenal in plasma and synovial fluid of patients with rheumatoid arthritis and osteoarthritisM L Selley, D J Bourne, M R Bartlett, et al.
Internal Medicine Journal|September 9, 2006
Etanercept in severe active rheumatoid arthritis: first Australian experienceL C Perera, K E Tymms, B J Wilson, et al.
International Journal of Rheumatic Diseases|July 22, 2017
Psoriatic arthritis treatment regimens, therapy duration and reasons for cessation in the biologics era: a multi-centre Australian studyKathleen Tymms, Ayano Kelly, Paul Bird, et al.
The Journal of Rheumatology|January 17, 2013
The SMILE study -- safety of methotrexate in combination with leflunomide in rheumatoid arthritisPaul Bird, Hedley Griffiths, Kathleen Tymms, et al.
The Journal of Biological Chemistry|August 22, 1997
A type I interferon signaling factor, ISF21, encoded on chromosome 21 is distinct from receptor components and their down-regulation and Is necessary for transcriptional activation of interferon-regulated genesK A Holland, C M Owczarek, S Y Hwang, et al.
Internal Medicine Journal|March 14, 2008
Infliximab in severe active ankylosing spondylitis with spinal ankylosisP P M Cheung, K E Tymms, B J Wilson, et al.
Rheumatology (Oxford, England)|May 16, 2020
Patients' attitudes and experiences of transition from paediatric to adult healthcare in rheumatology: a qualitative systematic reviewAyano Kelly, Fiona Niddrie, David J Tunnicliffe, et al.
Arthritis Care & Research|August 29, 2013
Barriers to optimal disease control for rheumatoid arthritis patients with moderate and high disease activityKathleen Tymms, Jane Zochling, James Scott, et al.
BMC Rheumatology|July 8, 2021
Researchers' perspectives on methodological challenges and outcomes selection in interventional studies targeting medication adherence in rheumatic diseases: an OMERACT-adherence studyShahrzad Salmasi, Ayano Kelly, Susan J Bartlett, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 21, 1995
A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responsesS Y Hwang, P J Hertzog, K A Holland, et al.
Pageof 16

Showing results (121-130 of 152) with videos related to

Sort By:
Pageof 16
Annals of the Rheumatic Diseases|April 1, 1992
Occurrence of (E)-4-hydroxy-2-nonenal in plasma and synovial fluid of patients with rheumatoid arthritis and osteoarthritisM L Selley, D J Bourne, M R Bartlett, et al.
Internal Medicine Journal|September 9, 2006
Etanercept in severe active rheumatoid arthritis: first Australian experienceL C Perera, K E Tymms, B J Wilson, et al.
International Journal of Rheumatic Diseases|July 22, 2017
Psoriatic arthritis treatment regimens, therapy duration and reasons for cessation in the biologics era: a multi-centre Australian studyKathleen Tymms, Ayano Kelly, Paul Bird, et al.
The Journal of Rheumatology|January 17, 2013
The SMILE study -- safety of methotrexate in combination with leflunomide in rheumatoid arthritisPaul Bird, Hedley Griffiths, Kathleen Tymms, et al.
The Journal of Biological Chemistry|August 22, 1997
A type I interferon signaling factor, ISF21, encoded on chromosome 21 is distinct from receptor components and their down-regulation and Is necessary for transcriptional activation of interferon-regulated genesK A Holland, C M Owczarek, S Y Hwang, et al.
Internal Medicine Journal|March 14, 2008
Infliximab in severe active ankylosing spondylitis with spinal ankylosisP P M Cheung, K E Tymms, B J Wilson, et al.
Rheumatology (Oxford, England)|May 16, 2020
Patients' attitudes and experiences of transition from paediatric to adult healthcare in rheumatology: a qualitative systematic reviewAyano Kelly, Fiona Niddrie, David J Tunnicliffe, et al.
Arthritis Care & Research|August 29, 2013
Barriers to optimal disease control for rheumatoid arthritis patients with moderate and high disease activityKathleen Tymms, Jane Zochling, James Scott, et al.
BMC Rheumatology|July 8, 2021
Researchers' perspectives on methodological challenges and outcomes selection in interventional studies targeting medication adherence in rheumatic diseases: an OMERACT-adherence studyShahrzad Salmasi, Ayano Kelly, Susan J Bartlett, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 21, 1995
A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responsesS Y Hwang, P J Hertzog, K A Holland, et al.
Pageof 16